These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 11791413)

  • 1. Autosomal dominant nephritis with renal failure of non-Alport type: clinical and molecular studies.
    Ilan T; Shohat T; Tobar A; Magal N; Yahav M; Halpern GJ; Rechavi G; Shohat M
    Isr Med Assoc J; 2001 Jul; 3(7):488-91. PubMed ID: 11791413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alport syndrome. Molecular genetic aspects.
    Hertz JM
    Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autosomal dominant Alport syndrome: molecular analysis of the COL4A4 gene and clinical outcome.
    Marcocci E; Uliana V; Bruttini M; Artuso R; Silengo MC; Zerial M; Bergesio F; Amoroso A; Savoldi S; Pennesi M; Giachino D; Rombolà G; Fogazzi GB; Rosatelli C; Martinhago CD; Carmellini M; Mancini R; Di Costanzo G; Longo I; Renieri A; Mari F
    Nephrol Dial Transplant; 2009 May; 24(5):1464-71. PubMed ID: 19129241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Familial interstitial nephritis with progressive renal failure.
    Zhang H; Wada J; Nanba K; Kunitomi M; Hida K; Nagake Y; Shikata K; Makino H
    Am J Kidney Dis; 2000 Oct; 36(4):E25. PubMed ID: 11007700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absence of ocular manifestations in autosomal dominant Alport syndrome associated with haematological abnormalties.
    Colville D; Wang YY; Jamieson R; Collins F; Hood J; Savige J
    Ophthalmic Genet; 2000 Dec; 21(4):217-25. PubMed ID: 11135492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Collagen type IV nephropathy: from thin basement membrane nephropathy to Alport syndrome].
    Endreffy E; Ondrik Z; Kemény E; Vas Z; Maróti Z; Lencse G; Bereczki C; Haszon I; Túri S; Iványi B
    Orv Hetil; 2005 Dec; 146(52):2647-53. PubMed ID: 16468607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Alport syndrome or progressive hereditary nephritis with hearing loss].
    Gubler MC; Heidet L; Antignac C
    Nephrol Ther; 2007 Jun; 3(3):113-20. PubMed ID: 17540313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hereditary glomerulonephritis of non-Alport type.
    Doherty CC; Middleton DT; Hill CM
    Proc Eur Dial Transplant Assoc; 1983; 19():575-81. PubMed ID: 6878256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical and genetic features of the Alport 'syndromes'].
    Pescucci C; Longo I; Mari F; Scala E; Bruttini M; Caselli R; Renieri A
    G Ital Nefrol; 2005; 22(5):466-76. PubMed ID: 16267804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and genetic mapping of X chromosome in the X-linked dominant inherited Alport's syndrome.
    Dai Y; Huang Y; He X; Wang S; Huang R; Tang M; Hu C
    Saudi J Kidney Dis Transpl; 2008 Sep; 19(5):767-74. PubMed ID: 18711293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel Cys1638Tyr NC1 domain substitution in alpha5(IV) collagen causes Alport syndrome with late onset renal failure without hearing loss or eye abnormalities.
    Wilson JC; Yoon HS; Walker RJ; Eccles MR
    Nephrol Dial Transplant; 2007 May; 22(5):1338-46. PubMed ID: 17277342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autosomal dominant Alport's syndrome: study of a large Tunisian family.
    Kharrat M; Makni S; Makni K; Kammoun K; Charfeddine K; Azaeiz H; Jarraya F; Ben Hmida M; Gubler MC; Ayadi H; Hachicha J
    Saudi J Kidney Dis Transpl; 2006 Sep; 17(3):320-5. PubMed ID: 16970251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A clinicopathological study of Alport syndrome and detection of type IV collagen chains in Alport patients.
    Chen N; Pan X; Ren H; Dong D
    Chin Med J (Engl); 1998 Sep; 111(9):797-802. PubMed ID: 11155669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hereditary nephritis in the bull terrier: evidence for inheritance by an autosomal dominant gene.
    Hood JC; Robinson WF; Huxtable CR; Bradley JS; Sutherland RJ; Thomas MA
    Vet Rec; 1990 May; 126(18):456-9. PubMed ID: 2356601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Familial hematuric nephropathies].
    Gubler MC
    Rev Prat; 1997 Sep; 47(14):1545-9. PubMed ID: 9366112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal prognosis in Alport's and related syndromes: influence of the mode of inheritance.
    Pochet JM; Bobrie G; Landais P; Goldfarb B; Grünfeld JP
    Nephrol Dial Transplant; 1989; 4(12):1016-21. PubMed ID: 2517321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the peripheral retinopathy in X-linked and autosomal recessive Alport syndrome.
    Shaw EA; Colville D; Wang YY; Zhang KW; Dagher H; Fassett R; Guymer R; Savige J
    Nephrol Dial Transplant; 2007 Jan; 22(1):104-8. PubMed ID: 17071739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Significance of family studies and kidney biopsies in children with renal hematuria].
    Pistor K; Bachmann H; Rumpelt HJ; Olbing H
    Monatsschr Kinderheilkd; 1985 May; 133(5):269-73. PubMed ID: 4010678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benign familial hematuria due to mutation of the type IV collagen alpha4 gene.
    Lemmink HH; Nillesen WN; Mochizuki T; Schröder CH; Brunner HG; van Oost BA; Monnens LA; Smeets HJ
    J Clin Invest; 1996 Sep; 98(5):1114-8. PubMed ID: 8787673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic, Clinical, and Pathologic Backgrounds of Patients with Autosomal Dominant Alport Syndrome.
    Kamiyoshi N; Nozu K; Fu XJ; Morisada N; Nozu Y; Ye MJ; Imafuku A; Miura K; Yamamura T; Minamikawa S; Shono A; Ninchoji T; Morioka I; Nakanishi K; Yoshikawa N; Kaito H; Iijima K
    Clin J Am Soc Nephrol; 2016 Aug; 11(8):1441-1449. PubMed ID: 27281700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.